Literature DB >> 16920384

Establishment of a murine model of bone invasion by oral squamous cell carcinoma.

Takeshi Nomura1, Takahiko Shibahara, Akira Katakura, Shizuka Matsubara, Nobuo Takano.   

Abstract

This study examines the establishment an animal model of bone invasion by oral squamous cell carcinoma to clarify the mechanisms of osteoclast-mediated bone invasion. C(3)H/HeN mice were inoculated with SCCVII cells into the masseter region. At the end of week 3, all surviving mice were sacrificed and analyzed by three-dimensional imaging using micro-computed tomography, histopathological observation using Hematoxylin-Eosin staining and Tartrate-Resistant Acid Phosphatase staining, and confirmation of mRNA expression of the osteoclast-related cytokines IL-6, TNF-alpha, and PTHrP. SCCVII cells rapidly multiplied in the masseter muscle of the mice. Bone invasion was evident only in the SCCVII transplanted group on micro-computed tomography. The histopathologic findings obtained with H-E and TRAP staining indicated that the tumor cells in the mandible of all animals of the SCCVII transplanted group exhibited funicular invasion and presented a serrated pattern of bone resorption. The mRNA expression of IL-6, PTHrP, and TNF-alpha increased as the control decreased. SCCVII cells were highly invasive into mandibular bone in C(3)H/HeN mice. This model was similar to the invasion of human oral cancer into maxillary and mandibular bone. Our mandibular invasion model may provide a powerful new modality for the diagnosis and treatment of oral cancer with bone invasion.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16920384     DOI: 10.1016/j.oraloncology.2006.03.015

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  12 in total

Review 1.  [Advances in molecular mechanisms of bone invasion by oral cancer].

Authors:  Wei Liu; Chun-Jie Li; Long-Jiang Li
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2021-04-01

2.  RANKL expression specifically observed in vivo promotes epithelial mesenchymal transition and tumor progression.

Authors:  Tamaki Yamada; Masumi Tsuda; Tomomi Takahashi; Yasunori Totsuka; Masanobu Shindoh; Yusuke Ohba
Journal:  Am J Pathol       Date:  2011-05-10       Impact factor: 4.307

3.  Autoregulation of RANK ligand in oral squamous cell carcinoma tumor cells.

Authors:  Yuvaraj Sambandam; Purushoth Ethiraj; Jessica D Hathaway-Schrader; Chad M Novince; Ezhil Panneerselvam; Kumaran Sundaram; Sakamuri V Reddy
Journal:  J Cell Physiol       Date:  2018-03-06       Impact factor: 6.384

4.  Zoledronic acid reduces bone loss and tumor growth in an orthotopic xenograft model of osteolytic oral squamous cell carcinoma.

Authors:  Chelsea K Martin; Jillian L Werbeck; Nanda K Thudi; Lisa G Lanigan; Tobie D Wolfe; Ramiro E Toribio; Thomas J Rosol
Journal:  Cancer Res       Date:  2010-10-19       Impact factor: 12.701

5.  Oral squamous carcinoma cells secrete RANKL directly supporting osteolytic bone loss.

Authors:  Xiaoyi Zhang; Carlos Rossa Junior; Min Liu; Fei Li; Nisha J D'Silva; Keith L Kirkwood
Journal:  Oral Oncol       Date:  2012-09-16       Impact factor: 5.337

6.  Role of CXC chemokine ligand 13 in oral squamous cell carcinoma associated osteolysis in athymic mice.

Authors:  Subramanya N M Pandruvada; Sambandam Yuvaraj; Xiang Liu; Kumaran Sundaram; Srinivasan Shanmugarajan; William L Ries; James S Norris; Steven D London; Sakamuri V Reddy
Journal:  Int J Cancer       Date:  2010-05-15       Impact factor: 7.396

7.  1α,25-dihydroxyvitamin D3 modulates CYP2R1 gene expression in human oral squamous cell carcinoma tumor cells.

Authors:  Kumaran Sundaram; Yuvaraj Sambandam; Eichi Tsuruga; Carol L Wagner; Sakamuri V Reddy
Journal:  Horm Cancer       Date:  2014-02-05       Impact factor: 3.869

8.  CXCL13 activation of c-Myc induces RANK ligand expression in stromal/preosteoblast cells in the oral squamous cell carcinoma tumor-bone microenvironment.

Authors:  Y Sambandam; K Sundaram; A Liu; K L Kirkwood; W L Ries; S V Reddy
Journal:  Oncogene       Date:  2012-02-13       Impact factor: 9.867

9.  The novel IκB kinase β inhibitor IMD-0560 prevents bone invasion by oral squamous cell carcinoma.

Authors:  Yukiyo Tada; Shoichiro Kokabu; Goro Sugiyama; Chihiro Nakatomi; Kazuhiro Aoki; Hidefumi Fukushima; Kenji Osawa; Yasutaka Sugamori; Keiichi Ohya; Masato Okamoto; Tomoyuki Fujikawa; Akiko Itai; Kou Matsuo; Seiji Watanabe; Eijiro Jimi
Journal:  Oncotarget       Date:  2014-12-15

10.  Intravenous magnetic nanoparticle cancer hyperthermia.

Authors:  Hui S Huang; James F Hainfeld
Journal:  Int J Nanomedicine       Date:  2013-07-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.